CAR-T Cell Therapy Market Application and Leading Players till 2030
The global CAR-T cell therapy market size was valued at USD 2.72 billion in 2022. The market is projected to grow from USD 4.38 billion in 2023 to USD 14.42 billion by 2030, exhibiting a CAGR of 18.5% during the forecast period.
Fortune Business Insights latest research report, titled “CAR-T
Cell Therapy Market: Global Industry Trends, Share, Size, Growth,
Opportunity, and Forecast 2023-2030,” provides a thorough analysis of the
market dynamics, segmentation, growth opportunities, trends, and competitive
landscape to comprehend the present and foreseeable market conditions. The
study provides a variety of market forecasts that take into account factors
such as revenue size, production, CAGR, consumption, growth opportunities,
industry trends and technologies, and other essential elements. The report
provides a comprehensive analysis of the next trends and developments in CAR-T
Cell Therapy Market, while highlighting the key driving and restraining forces
in this market. The CAR-T Cell Therapy Market industry assessment includes the
key market trends with respect to the current situation and anticipated
advancements.
CAR-T Cell Therapy:
- Involves modifying specialized T-cells to target and
eliminate cancer cells.
- Increasing cancer incidence and healthcare burden driving
the need for innovative therapies.
- 19,292,789 newly diagnosed cancer cases worldwide in 2020,
with 9,958,133 deaths.
Request a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108455
Market Overview:
Here, we examine the current state of the market, including
its size, growth trends, segmentation, industry structure, and the competitive
landscape. Statistical data, graphs, and charts may be included to support our
findings.
In other words, we will provide a comprehensive overview of
the market, including its size, growth trends, segmentation, industry
structure, and the competitive landscape. We will also include statistical
data, graphs, and charts to support our findings.
Latest Trends:
- Increasing number of clinical trials and research &
development initiatives.
- 443 pipeline candidates and 12 clinical trials in 2012,
showcasing growth.
- Industry collaborations and clinical trial outcomes
contributing to advancements.
- Examples of recent clinical trials and collaborations.
Driving Factors:
- Rising global cancer prevalence and patient assistance
programs.
- Government initiatives to raise cancer awareness.
- Estimated increase to 27.5 million new cancer cases and
16.3 million deaths by 2040.
- Over 60% projected increase in global cancer cases by
2040.
Major Key Players Are:
- Gilead
Sciences, Inc. (U.S.)
- Novartis
AG (Switzerland)
- Bristol-Myers
Squibb Company (U.S.)
- Johnson
& Johnson Services, Inc. (Janssen Global Services, LLC) (U.S.)
- Caribou
Biosciences, Inc. (U.S.)
- CARsgenTherapeutics
Co., Ltd (China)
- JW
Therapeutics (Shanghai) Co., Ltd. (China)
- Cartesian
Therapeutics, Inc. (U.S.)
- Aurora
Biopharma (U.S.)
Objectives:
The primary objectives of this market research project
are as follows:
- Choose
and describe the target market.
- Analyze
the dynamics and trends in the market today.
- Examine
the positioning of the market and competitor strategies.
- Recognize
the preferences and purchasing patterns of customers.
- Analyze
the industry's opportunities and challenges.
- On
the basis of the research findings, offer practical recommendations.
The Report Includes
- Research
Methodology
- Report
Introduction
- List
of Table & Figures
- Overview
of the Market
- Regional
Analysis
- Graphical
Representation of Size, Trends, and Shares
- In-Depth
Industry Analysis
- Opportunities
Present In the Market
- Market
Restraints
What are the key dynamic factors that are detailed in the
report?
Key Market Dynamics: The CAR-T Cell Therapy Market
research report covers the most recent market trends, expansion patterns, and
research techniques. The production strategies and methodologies, development
platforms, and the product model themselves are the factors that directly
influence the market's growth, and even a minor adjustment can cause further
changes to the report as a whole. The research study goes into great detail to
explain each of these factors.
Market Outlook: On a regional and international
level, the report discusses some of the key factors, such as R&D, new
product launches, M&A, agreements, partnerships, joint ventures,
collaborations, and growth of the key industry participants.
Major Features: The report analyzes costs, capacity,
production, revenue, consumption, import/export, supply/demand, gross, market
share, CAGR, and gross margin. It also studies key influencing factors and
market inclinations.
Analytical Tools: The CAR-T Cell Therapy Market
report contains information that has been thoroughly researched and evaluated
about the major players and the scope of their markets using a variety of
analytical tools, such as SWOT analysis, Porter's five forces analysis,
investment return analysis, and feasibility study. These tools have been used
to efficiently study the growth of major industry participants.
Potential Customers: The report provides in-depth
information to users, service providers, suppliers, manufacturers,
stockholders, and individuals who are interested in evaluating or self-studying
this market.
Ask For Customization: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/108455
Related Reports:
Sternal
Closure Systems Market
Sickle
Cell Disease Treatment Market
Anxiety
Disorders and Depression Treatment Market
About us:
Fortune Business Insights™ provides accurate data and
innovative enterprise analytics to help organizations of all sizes make better
decisions. We tailor novel solutions for our clients to help them meet a
variety of unique business challenges. Our aim is to provide a detailed
overview of the markets in which they operate to provide holistic market
intelligence.
Address:
Fortune Business Insights Pvt.
9th Floor, Icon Tower, Baner –
Pune-411045,
India, Maharashtra.
Telephone:
USA: +1 424 253 0390
UK: +44 2071 939123
Asia Pacific: +91 744 740 1245
Comments
Post a Comment